Abstract
Glial cell activation plays an important role in the pathogenesis of various neurodegenerative disorders. This article presents a protocol for the preparation of cultures consisting of rat embryonic cortical neurons grown in the presence of cortical microglia, in which the glia are present in physical contact with the neurons or separated by a semi-permeable membrane barrier.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Griffin WS, Sheng JG, Royston MC, Royston MC, Gentleman SM, McKenzie JE, et al (1998) Glial-neuronal interactions in Alzheimer’s disease: the potential role of a “cytokine cycle” in disease progression. Brain Pathol 8, 65–72
Colton CA, and Wilcock DM (2010) Assessing activation states in microglia. CNS Neurol Disord Drug Targets 9, 174–191
Craft JM, Watterson DM, and Van Eldik LJ (2005) Neuroinflammation: a potential therapeutic target. Expert Opin. Ther Targets 9, 887–900
Skaper SD (2010) Microglia as a target for inflammatory processes and neuroprotective strategies. Am J Neuroprotec Neuroregen 2, 35–47
Skaper SD (2011) Ion channels on microglia: therapeutic targets for neuroprotection. CNS Neurol Disord Drug Targets, 10, 44–56
Chao CC, Hu S, Molitor TW, Shaskan EG, and Peterson PK (1992) Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 149, 2736–2741
Flavin MP, Zhao G, and Ho LT (2000) Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 29, 347–354
Golde S, Chandran S, Brown GC, and Compston A (2002) Different pathways for iNOS-mediated toxicity in vitro dependent on neuronal maturation and NMDA receptor expression. J Neurochem 82, 269–282
Parvathenani LK, Tertyshnikova S, Greco CR, Roberts SB, Robertson B, and Pos-mantur R (2003) P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer’s disease. J Biol Chem 278, 13309–13317
Culbert AA, Skaper SD, Howlett DR, Evans NA, Facci L, Soden PE, et al. (2006) MAPKAP kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity: Relevance to neuroinflammation in a transgenic mouse model of Alzheimer’s disease. J Biol Chem 281, 23658–23667
Skaper SD, Facci L, Culbert A, Evans NA, Chessell I, Davis JB, et al. (2006) P2X7 receptors on microglial cells mediate injury to cortical neurons in vitro. Glia 54, 234–242
Jana A, and Pahan K (2010) Fibrillar amyloid-β-activated human astroglia kill primary human neurons via neutral sphingomyelinase: implications for Alzheimer’s disease. J Neurosci 30, 12676–12689
Acknowledgments
L. Facci was supported by Fondazione CARIPARO Progetto Dottorati di Ricerca’ Anno 2009.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Skaper, S.D., Facci, L. (2012). Central Nervous System Neuron-Glia Co-culture Models. In: Skaper, S. (eds) Neurotrophic Factors. Methods in Molecular Biology, vol 846. Humana Press. https://doi.org/10.1007/978-1-61779-536-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-61779-536-7_8
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-535-0
Online ISBN: 978-1-61779-536-7
eBook Packages: Springer Protocols